Bank of New York Mellon’s Puma Biotechnology PBYI Stock Holding History

Bank of New York Mellon’s Portfolio PBYI Stock Details PBYI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.93M	Buy	360,734 +12,853	+4%	+$94.1K	﹤0.01%	2733
2026 Q1	$2.22M	Sell	347,881 -4,000	-1%	-$25.8K	﹤0.01%	2750
2025 Q4	$2.09M	Sell	351,881 -3,487	-1%	-$18.5K	﹤0.01%	2802
2025 Q3	$1.89M	Buy	355,368 +11,285	+3%	+$47.9K	﹤0.01%	2833
2025 Q2	$1.18M	Buy	344,083 +3,197	+0.9%	+$10.2K	﹤0.01%	3044
2025 Q1	$1.01M	Buy	340,886 +9,033	+3%	+$28.3K	﹤0.01%	3065
2024 Q4	$1.01M	Buy	331,853 +54,150	+19%	+$158K	﹤0.01%	3156
2024 Q3	$708K	Sell	277,703 -31,294	-10%	-$94.7K	﹤0.01%	3322
2024 Q2	$1.01M	Buy	308,997 +120,104	+64%	+$527K	﹤0.01%	3200
2024 Q1	$1M	Buy	188,893 +142,460	+307%	+$767K	﹤0.01%	3152
2023 Q4	$201K	Sell	46,433 -6,490	-12%	-$21.5K	﹤0.01%	3952
2023 Q3	$139K	Sell	52,923 -19,345	-27%	-$65.9K	﹤0.01%	4044
2023 Q2	$255K	Sell	72,268 -1,095	-1%	-$3.42K	﹤0.01%	3901
2023 Q1	$227K	Buy	73,363 +15,360	+26%	+$57.9K	﹤0.01%	3867
2022 Q4	$245K	Buy	58,003 +27,970	+93%	+$96.5K	﹤0.01%	3887
2022 Q3	$71K	Sell	30,033 -2,019	-6%	-$5.89K	﹤0.01%	4264
2022 Q2	$91K	Sell	32,052 -83,344	-72%	-$207K	﹤0.01%	4241
2022 Q1	$332K	Sell	115,396 -700	-0.6%	-$1.81K	﹤0.01%	3959
2021 Q4	$354K	Sell	116,096 -3,585	-3%	-$15.6K	﹤0.01%	4003
2021 Q3	$839K	Buy	119,681 +6,913	+6%	+$51.8K	﹤0.01%	3495
2021 Q2	$1.03M	Sell	112,768 -23,037	-17%	-$233K	﹤0.01%	3396
2021 Q1	$1.32M	Sell	135,805 -4,929	-4%	-$55K	﹤0.01%	3179
2020 Q4	$1.44M	Sell	140,734 -8,197	-6%	-$83K	﹤0.01%	3029
2020 Q3	$1.5M	Sell	148,931 -619	-0.4%	-$6.3K	﹤0.01%	2853
2020 Q2	$1.56M	Sell	149,550 -21,047	-12%	-$218K	﹤0.01%	2824
2020 Q1	$1.44M	Sell	170,597 -2,860	-2%	-$27.8K	﹤0.01%	2727
2019 Q4	$1.52M	Buy	173,457 +5,386	+3%	+$44.6K	﹤0.01%	2994
2019 Q3	$1.81M	Buy	168,071 +9,665	+6%	+$104K	﹤0.01%	2803
2019 Q2	$2.01M	Sell	158,406 -20,303	-11%	-$468K	﹤0.01%	2794
2019 Q1	$6.93M	Buy	178,709 +14,693	+9%	+$449K	﹤0.01%	2175
2018 Q4	$3.34M	Sell	164,016 -24,285	-13%	-$729K	﹤0.01%	2492
2018 Q3	$8.63M	Buy	188,301 +6,115	+3%	+$295K	﹤0.01%	2113
2018 Q2	$10.8M	Sell	182,186 -702	-0.4%	-$40.7K	﹤0.01%	1982
2018 Q1	$12.4M	Buy	182,888 +6,422	+4%	+$481K	﹤0.01%	1870
2017 Q4	$17.4M	Sell	176,466 -5,832	-3%	-$653K	﹤0.01%	1652
2017 Q3	$21.8M	Buy	182,298 +46,001	+34%	+$4.28M	0.01%	1502
2017 Q2	$11.9M	Buy	136,297 +2,072	+2%	+$116K	﹤0.01%	1867
2017 Q1	$4.99M	Sell	134,225 -23,561	-15%	-$860K	﹤0.01%	2323
2016 Q4	$4.84M	Sell	157,786 -657	-0.4%	-$28.4K	﹤0.01%	2330
2016 Q3	$10.6M	Buy	158,443 +46,525	+42%	+$2.35M	﹤0.01%	1850
2016 Q2	$3.33M	Buy	111,918 +5,423	+5%	+$170K	﹤0.01%	2428
2016 Q1	$3.13M	Buy	106,495 +3,633	+4%	+$164K	﹤0.01%	2413
2015 Q4	$8.06M	Sell	102,862 -13,800	-12%	-$1.08M	﹤0.01%	1959
2015 Q3	$8.79M	Buy	116,662 +14,151	+14%	+$1.34M	﹤0.01%	1931
2015 Q2	$12M	Sell	102,511 -32,166	-24%	-$5.83M	﹤0.01%	1862
2015 Q1	$31.8M	Buy	134,677 +11,460	+9%	+$2.45M	0.01%	1173
2014 Q4	$23.3M	Sell	123,217 -4,050	-3%	-$899K	0.01%	1355
2014 Q3	$30.4M	Buy	127,267 +19,817	+18%	+$4.07M	0.01%	1163
2014 Q2	$7.09M	Sell	107,450 -12,387	-10%	-$881K	﹤0.01%	2130
2014 Q1	$12.5M	Buy	119,837 +11,988	+11%	+$1.41M	﹤0.01%	1760
2013 Q4	$11.2M	Sell	107,849 -109,963	-50%	-$6.45M	﹤0.01%	1825
2013 Q3	$11.7M	Sell	217,812 -38,834	-15%	-$2.09M	﹤0.01%	1748
2013 Q2	$11.4M	Buy	+256,646	New	+$9.05M	﹤0.01%	1708

Other funds holding PBYI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RWM

Ritholtz Wealth Management New York $6.7B AUM 32.7% 1-Year Est. Return

State Board of Administration of Florida Retirement System Tallahassee, Florida $60.3B AUM 42.74% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

PFS

Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return

Haven Private Orlando, Florida $263M AUM 21.06% 1-Year Est. Return

STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

Bank of New York Mellon's PBYI Position: Q2 2026 in Review

Bank of New York Mellon increased its Puma Biotechnology (PBYI) stake by 3.7% in Q2 2026, buying an estimated $94.1K and bringing the position to 360,734 shares worth $2.93M. The position accounts for ﹤0.01% of the portfolio, ranked #2733.

Bank of New York Mellon first reported a position in PBYI in Q2 2013 and has held it in 53 quarters since. The position peaked at $31.8M in Q1 2015. 72 funds tracked by Wall St. Rank hold PBYI as of Q2 2026.

Bank of New York Mellon held 360,734 shares of Puma Biotechnology worth $2.93M as of Q2 2026.
Bank of New York Mellon bought 12,853 Puma Biotechnology shares in Q2 2026, an estimated $94.1K.
Puma Biotechnology made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #2733 holding.
Bank of New York Mellon first reported a position in Puma Biotechnology in Q2 2013 and has held it in 53 quarters since.
Bank of New York Mellon's Puma Biotechnology position peaked at $31.8M in Q1 2015.
72 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.